应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
APVO Aptevo Therapeutics Inc.
休市中 07-11 16:00:00 EDT
3.00
-0.01
-0.33%
盘后
2.98
-0.02
-0.67%
19:57 EDT
最高
3.01
最低
2.94
成交量
12.94万
今开
2.97
昨收
3.01
日振幅
2.33%
总市值
967.26万
流通市值
967.23万
总股本
322.42万
成交额
38.47万
换手率
4.01%
流通股本
322.41万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Aptevo Therapeutics Inc.6月24日成交额为433.61万美元
市场透视 · 06-25
Aptevo Therapeutics Inc.6月24日成交额为433.61万美元
美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO.US)飙升超130%
智通财经 · 06-18
美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO.US)飙升超130%
【美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO
智通财经 · 06-18
【美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO
Aptevo Therapeutics Inc.6月16日成交额为56.31万美元
市场透视 · 06-17
Aptevo Therapeutics Inc.6月16日成交额为56.31万美元
Aptevo Therapeutics Inc.6月13日成交额为66.73万美元
市场透视 · 06-14
Aptevo Therapeutics Inc.6月13日成交额为66.73万美元
Aptevo Therapeutics Inc.5月27日成交额为84.86万美元
市场透视 · 05-28
Aptevo Therapeutics Inc.5月27日成交额为84.86万美元
Aptevo Therapeutics Inc.5月23日成交额为58.02万美元
市场透视 · 05-24
Aptevo Therapeutics Inc.5月23日成交额为58.02万美元
Aptevo Therapeutics Inc.盘中异动 早盘大幅下挫9.63%报0.271美元
市场透视 · 05-23
Aptevo Therapeutics Inc.盘中异动 早盘大幅下挫9.63%报0.271美元
Aptevo Therapeutics Inc.盘中异动 急速下跌21.05%报0.300美元
市场透视 · 05-22
Aptevo Therapeutics Inc.盘中异动 急速下跌21.05%报0.300美元
Aptevo Therapeutics Inc.5月21日成交额为6278.56万美元
市场透视 · 05-22
Aptevo Therapeutics Inc.5月21日成交额为6278.56万美元
Aptevo Therapeutics Inc.5月20日成交额为13.14万美元
市场透视 · 05-21
Aptevo Therapeutics Inc.5月20日成交额为13.14万美元
Aptevo Therapeutics Inc.盘中异动 临近午盘股价大涨5.13%
市场透视 · 05-20
Aptevo Therapeutics Inc.盘中异动 临近午盘股价大涨5.13%
Aptevo Therapeutics Inc.5月19日成交额为20.84万美元
市场透视 · 05-20
Aptevo Therapeutics Inc.5月19日成交额为20.84万美元
Aptevo Therapeutics Inc.5月16日成交额为17.63万美元
市场透视 · 05-17
Aptevo Therapeutics Inc.5月16日成交额为17.63万美元
Aptevo Therapeutics Inc.5月14日成交额为25.01万美元
市场透视 · 05-15
Aptevo Therapeutics Inc.5月14日成交额为25.01万美元
Aptevo Therapeutics Inc.5月13日成交额为46.32万美元
市场透视 · 05-14
Aptevo Therapeutics Inc.5月13日成交额为46.32万美元
Aptevo Therapeutics Inc.盘中异动 早盘大幅跳水5.15%
市场透视 · 05-07
Aptevo Therapeutics Inc.盘中异动 早盘大幅跳水5.15%
Aptevo Therapeutics Inc.5月5日成交额为169.69万美元
市场透视 · 05-06
Aptevo Therapeutics Inc.5月5日成交额为169.69万美元
Aptevo Therapeutics Inc.股价重挫13.63% 市值跌32.68万美元
市场透视 · 05-05
Aptevo Therapeutics Inc.股价重挫13.63% 市值跌32.68万美元
Aptevo Therapeutics Inc.盘中异动 股价大涨5.07%报0.524美元
市场透视 · 05-02
Aptevo Therapeutics Inc.盘中异动 股价大涨5.07%报0.524美元
加载更多
公司概况
公司名称:
Aptevo Therapeutics Inc.
所属市场:
NASDAQ
上市日期:
--
主营业务:
Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司,专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术,用于合理设计精准免疫调节药物。该公司的主要临床候选药物APVO436和ALG.APV-527以及临床前候选药物APVO603和APVO711是使用ADAPTIR模块蛋白技术平台开发的。该公司的临床前候选药物APVO442是利用ADAPTIR-FLEX模块蛋白技术平台开发的。该公司的ADAPTIR和ADAPTIR-FLEX平台旨在产生能够增强人体免疫系统对抗癌细胞的单特异性、双特异性和多特异性候选抗体。
发行价格:
--
{"stockData":{"symbol":"APVO","market":"US","secType":"STK","nameCN":"Aptevo Therapeutics Inc.","latestPrice":3,"timestamp":1752264000000,"preClose":3.01,"halted":0,"volume":129353,"hourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":3,"latestTime":"19:57 EDT","volume":3703,"amount":10963.5442,"timestamp":1752278260940},"delay":0,"floatShares":3224100,"shares":3224200,"eps":-1747.6832,"marketStatus":"休市中","change":-0.01,"latestTime":"07-11 16:00:00 EDT","open":2.97,"high":3.01,"low":2.94,"amount":384732.7005403,"amplitude":0.023256,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1747.6832,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1752480000000},"marketStatusCode":7,"adr":0,"adrRate":0,"exchange":"NASDAQ","adjPreClose":3.01,"preHourTrading":{"tag":"盘前","latestPrice":2.9873,"preClose":3.01,"latestTime":"09:20 EDT","volume":1279,"amount":3857.9479736,"timestamp":1752240037488},"postHourTrading":{"tag":"盘后","latestPrice":2.98,"preClose":3,"latestTime":"19:57 EDT","volume":3703,"amount":10963.5442,"timestamp":1752278260940},"volumeRatio":0.6857709666400783},"requestUrl":"/m/hq/s/APVO","defaultTab":"news","newsList":[{"id":"2546525088","title":"Aptevo Therapeutics Inc.6月24日成交额为433.61万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2546525088","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2546525088?lang=zh_cn&edition=full","pubTime":"2025-06-25 09:16","pubTimestamp":1750814213,"startTime":"0","endTime":"0","summary":"美东时间2025年6月24日,Aptevo Therapeutics Inc.成交额为433.61万美元,成交额较昨日减少5.77%,当日成交量为119.35万股。Aptevo Therapeutics Inc.于2025年6月24日涨6.46%,报3.46美元,该股过去5个交易日跌5.46%,年初至今跌95.99%,过去60日跌86.16%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-24|433.61万|-5.77%|119.35万|#|2025-06-23|460.17万|-65.75%|128.68万|#|2025-06-20|1343.48万|-98.62%|322.58万|#|2025-06-18|9.70亿|107168.47%|1.24亿|#|2025-06-17|90.45万|60.64%|26.88万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091706a71c1047&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250625091706a71c1047&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","LENZ","BK4007","APVO"],"gpt_icon":1},{"id":"2544909909","title":"美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO.US)飙升超130%","url":"https://stock-news.laohu8.com/highlight/detail?id=2544909909","media":"智通财经","labels":["dataReport","movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544909909?lang=zh_cn&edition=full","pubTime":"2025-06-18 23:41","pubTimestamp":1750261300,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,周三,Aptevo Therapeutics(APVO.US)飙升超130%,报6.52美元。消息面上,该公司表示,其mipletamig组合疗法在前线急性髓性白血病患者中达到85%的缓解率。根据Aptevo所述的1b/2期Rainer试验结果,mipletamig的治疗方法在不适合化疗的患者中显示出强大的疗效和安全性。该试验的第3组正在以测试的最高剂量水平接近完全入组,公司的乐观态度使其对mipletamig的潜力充满信心。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1306994.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport,movement","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK4007","LENZ","BK4139","APVO","BK4539"],"gpt_icon":0},{"id":"2544790990","title":"【美股异动 | Mipletamig疗法在白血病患者中达到85%缓解率 Aptevo Therapeutics(APVO","url":"https://stock-news.laohu8.com/highlight/detail?id=2544790990","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544790990?lang=zh_cn&edition=full","pubTime":"2025-06-18 23:41","pubTimestamp":1750261300,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["BK4007","LENZ","BK4539","APVO","BK4139"],"gpt_icon":0},{"id":"2544987530","title":"Aptevo Therapeutics Inc.6月16日成交额为56.31万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2544987530","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2544987530?lang=zh_cn&edition=full","pubTime":"2025-06-17 09:17","pubTimestamp":1750123022,"startTime":"0","endTime":"0","summary":"美东时间2025年6月16日,Aptevo Therapeutics Inc.成交额为56.31万美元,成交额较昨日减少15.62%,当日成交量为14.85万股。Aptevo Therapeutics Inc.于2025年6月16日跌16.63%,报3.66美元,该股过去5个交易日跌21.79%,年初至今跌95.75%,过去60日跌92.59%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-16|56.31万|-15.62%|14.85万|#|2025-06-13|66.73万|481.09%|14.81万|#|2025-06-12|11.48万|-68.74%|2.48万|#|2025-06-11|36.74万|214.73%|7.76万|#|2025-06-10|11.67万|-69.70%|2.51万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091713a4ad2b52&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250617091713a4ad2b52&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","LENZ","BK4539","APVO","BK4139"],"gpt_icon":0},{"id":"2543651367","title":"Aptevo Therapeutics Inc.6月13日成交额为66.73万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2543651367","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2543651367?lang=zh_cn&edition=full","pubTime":"2025-06-14 09:17","pubTimestamp":1749863821,"startTime":"0","endTime":"0","summary":"美东时间2025年6月13日,Aptevo Therapeutics Inc.成交额为66.73万美元,成交额较昨日增加481.09%,当日成交量为14.81万股。Aptevo Therapeutics Inc.于2025年6月13日跌8.16%,报4.39美元,该股过去5个交易日跌11.31%,年初至今跌94.91%,过去60日跌91.65%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-06-13|66.73万|481.09%|14.81万|#|2025-06-12|11.48万|-68.74%|2.48万|#|2025-06-11|36.74万|214.73%|7.76万|#|2025-06-10|11.67万|-69.70%|2.51万|#|2025-06-09|38.53万|29.56%|7.97万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091708a4a87407&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250614091708a4a87407&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","BK4139","APVO","BK4007","LENZ"],"gpt_icon":0},{"id":"2538419896","title":"Aptevo Therapeutics Inc.5月27日成交额为84.86万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2538419896","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2538419896?lang=zh_cn&edition=full","pubTime":"2025-05-28 09:16","pubTimestamp":1748395009,"startTime":"0","endTime":"0","summary":"美东时间2025年5月27日,Aptevo Therapeutics Inc.成交额为84.86万美元,成交额较昨日增加46.26%,当日成交量为17.47万股。Aptevo Therapeutics Inc.于2025年5月27日跌10.68%,报4.92美元,该股过去5个交易日跌20.65%,年初至今跌94.29%,过去60日跌93.56%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-27|84.86万|46.26%|17.47万|#|2025-05-23|58.02万|-64.76%|215.09万|#|2025-05-22|164.62万|-97.38%|528.60万|#|2025-05-21|6278.56万|47663.84%|1.19亿|#|2025-05-20|13.14万|-36.93%|41.73万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528091721a6ef9026&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250528091721a6ef9026&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4539","APVO","BK4007","BK4139"],"gpt_icon":0},{"id":"2537232165","title":"Aptevo Therapeutics Inc.5月23日成交额为58.02万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537232165","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537232165?lang=zh_cn&edition=full","pubTime":"2025-05-24 09:16","pubTimestamp":1748049399,"startTime":"0","endTime":"0","summary":"美东时间2025年5月23日,Aptevo Therapeutics Inc.成交额为58.02万美元,成交额较昨日减少64.76%,当日成交量为215.09万股。Aptevo Therapeutics Inc.于2025年5月23日跌8.2%,报0.275美元,该股过去5个交易日跌13.94%,年初至今跌93.61%,过去60日跌92.33%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-23|58.02万|-64.76%|215.09万|#|2025-05-22|164.62万|-97.38%|528.60万|#|2025-05-21|6278.56万|47663.84%|1.19亿|#|2025-05-20|13.14万|-36.93%|41.73万|#|2025-05-19|20.84万|18.20%|68.69万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524091649a48a4b85&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250524091649a48a4b85&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","BK4539","BK4007","LENZ"],"gpt_icon":0},{"id":"2537134790","title":"Aptevo Therapeutics Inc.盘中异动 早盘大幅下挫9.63%报0.271美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537134790","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537134790?lang=zh_cn&edition=full","pubTime":"2025-05-23 21:32","pubTimestamp":1748007151,"startTime":"0","endTime":"0","summary":"北京时间2025年05月23日21时32分,Aptevo Therapeutics Inc.股票出现波动,股价急速下跌9.63%。截至发稿,该股报0.271美元/股,成交量48.6873万股,换手率6.00%,振幅5.57%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.82%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213231a6ea5e43&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250523213231a6ea5e43&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","BK4007","BK4539","LENZ"],"gpt_icon":0},{"id":"2537944579","title":"Aptevo Therapeutics Inc.盘中异动 急速下跌21.05%报0.300美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537944579","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537944579?lang=zh_cn&edition=full","pubTime":"2025-05-22 21:31","pubTimestamp":1747920696,"startTime":"0","endTime":"0","summary":"北京时间2025年05月22日21时31分,Aptevo Therapeutics Inc.股票出现波动,股价快速下跌21.05%。截至发稿,该股报0.300美元/股,成交量190.037万股,换手率23.43%,振幅6.05%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.26%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213136a6e8f15b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522213136a6e8f15b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4539","LENZ","BK4007","BK4139","APVO"],"gpt_icon":0},{"id":"2537496570","title":"Aptevo Therapeutics Inc.5月21日成交额为6278.56万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537496570","media":"市场透视","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537496570?lang=zh_cn&edition=full","pubTime":"2025-05-22 09:16","pubTimestamp":1747876590,"startTime":"0","endTime":"0","summary":"美东时间2025年5月21日,Aptevo Therapeutics Inc.成交额为6278.56万美元,成交额较昨日增加47663.84%,当日成交量为1.19亿股。Aptevo Therapeutics Inc.于2025年5月21日涨22.62%,报0.38美元,该股过去5个交易日涨15.15%,年初至今跌91.18%,过去60日跌87.62%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-21|6278.56万|47663.84%|1.19亿|#|2025-05-20|13.14万|-36.93%|41.73万|#|2025-05-19|20.84万|18.20%|68.69万|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522091649a6e816f6&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250522091649a6e816f6&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4007","APVO","BK4539","LENZ"],"gpt_icon":0},{"id":"2537620222","title":"Aptevo Therapeutics Inc.5月20日成交额为13.14万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2537620222","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2537620222?lang=zh_cn&edition=full","pubTime":"2025-05-21 09:16","pubTimestamp":1747790189,"startTime":"0","endTime":"0","summary":"美东时间2025年5月20日,Aptevo Therapeutics Inc.成交额为13.14万美元,成交额较昨日减少36.93%,当日成交量为41.73万股。Aptevo Therapeutics Inc.于2025年5月20日跌0.03%,报0.31美元,该股过去5个交易日跌8.85%,年初至今跌92.81%,过去60日跌90.35%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-20|13.14万|-36.93%|41.73万|#|2025-05-19|20.84万|18.20%|68.69万|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|#|2025-05-14|25.01万|-46.00%|75.71万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521091634a6e6ab1a&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250521091634a6e6ab1a&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4007","BK4139","BK4539","APVO"],"gpt_icon":0},{"id":"2536416956","title":"Aptevo Therapeutics Inc.盘中异动 临近午盘股价大涨5.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2536416956","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536416956?lang=zh_cn&edition=full","pubTime":"2025-05-20 23:40","pubTimestamp":1747755613,"startTime":"0","endTime":"0","summary":"北京时间2025年05月20日23时40分,Aptevo Therapeutics Inc.股票出现波动,股价大幅拉升5.13%。截至发稿,该股报0.326美元/股,成交量19.7424万股,换手率3.56%,振幅4.87%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.45%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234014aa2c943e&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520234014aa2c943e&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","APVO"],"gpt_icon":0},{"id":"2536654077","title":"Aptevo Therapeutics Inc.5月19日成交额为20.84万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536654077","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536654077?lang=zh_cn&edition=full","pubTime":"2025-05-20 09:16","pubTimestamp":1747703788,"startTime":"0","endTime":"0","summary":"美东时间2025年5月19日,Aptevo Therapeutics Inc.成交额为20.84万美元,成交额较昨日增加18.20%,当日成交量为68.69万股。Aptevo Therapeutics Inc.于2025年5月19日跌3.13%,报0.31美元,该股过去5个交易日跌8.82%,年初至今跌92.81%,过去60日跌91.07%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-19|20.84万|18.20%|68.69万|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|#|2025-05-14|25.01万|-46.00%|75.71万|#|2025-05-13|46.32万|110.05%|136.67万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520091645a484af6f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250520091645a484af6f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","LENZ","BK4539","BK4007"],"gpt_icon":0},{"id":"2536706375","title":"Aptevo Therapeutics Inc.5月16日成交额为17.63万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2536706375","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2536706375?lang=zh_cn&edition=full","pubTime":"2025-05-17 09:16","pubTimestamp":1747444585,"startTime":"0","endTime":"0","summary":"美东时间2025年5月16日,Aptevo Therapeutics Inc.成交额为17.63万美元,成交额较昨日减少29.41%,当日成交量为54.05万股。Aptevo Therapeutics Inc.于2025年5月16日跌3.03%,报0.32美元,该股过去5个交易日跌5.88%,年初至今跌92.58%,过去60日跌90.62%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-16|17.63万|-29.41%|54.05万|#|2025-05-15|24.98万|-0.12%|75.49万|#|2025-05-14|25.01万|-46.00%|75.71万|#|2025-05-13|46.32万|110.05%|136.67万|#|2025-05-12|22.05万|1.21%|65.01万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517091642a48185ea&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250517091642a48185ea&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["APVO","BK4007","BK4139","BK4539","LENZ"],"gpt_icon":0},{"id":"2535837133","title":"Aptevo Therapeutics Inc.5月14日成交额为25.01万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535837133","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535837133?lang=zh_cn&edition=full","pubTime":"2025-05-15 09:16","pubTimestamp":1747271802,"startTime":"0","endTime":"0","summary":"美东时间2025年5月14日,Aptevo Therapeutics Inc.成交额为25.01万美元,成交额较昨日减少46.00%,当日成交量为75.71万股。Aptevo Therapeutics Inc.于2025年5月14日跌2.94%,报0.33美元,该股过去5个交易日跌15.38%,年初至今跌92.34%,过去60日跌90.54%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-14|25.01万|-46.00%|75.71万|#|2025-05-13|46.32万|110.05%|136.67万|#|2025-05-12|22.05万|1.21%|65.01万|#|2025-05-09|21.79万|-18.98%|63.37万|#|2025-05-08|26.89万|-8.72%|75.12万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515091658a6dfa472&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250515091658a6dfa472&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","APVO","BK4539","LENZ","BK4139"],"gpt_icon":0},{"id":"2535055833","title":"Aptevo Therapeutics Inc.5月13日成交额为46.32万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2535055833","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2535055833?lang=zh_cn&edition=full","pubTime":"2025-05-14 09:16","pubTimestamp":1747185384,"startTime":"0","endTime":"0","summary":"美东时间2025年5月13日,Aptevo Therapeutics Inc.成交额为46.32万美元,成交额较昨日增加110.05%,当日成交量为136.67万股。Aptevo Therapeutics Inc.于2025年5月13日涨0.0%,报0.34美元,该股过去5个交易日跌17.07%,年初至今跌92.11%,过去60日跌89.82%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-13|46.32万|110.05%|136.67万|#|2025-05-12|22.05万|1.21%|65.01万|#|2025-05-09|21.79万|-18.98%|63.37万|#|2025-05-08|26.89万|-8.72%|75.12万|#|2025-05-07|29.46万|22.14%|74.78万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514091634a47d6a33&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250514091634a47d6a33&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","BK4539","BK4007","LENZ","APVO"],"gpt_icon":0},{"id":"2533936522","title":"Aptevo Therapeutics Inc.盘中异动 早盘大幅跳水5.15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2533936522","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533936522?lang=zh_cn&edition=full","pubTime":"2025-05-07 21:33","pubTimestamp":1746624818,"startTime":"0","endTime":"0","summary":"北京时间2025年05月07日21时33分,Aptevo Therapeutics Inc.股票出现异动,股价快速跳水5.15%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.13%。其相关个股中,Lakeshore Biopharma Co Ltd C/Wts 15/03/2028 、Rigel Pharmaceuticals, Inc.、Liminatus Pharma, Inc.涨幅较大,Theriva Biologics, Inc.、Zyversa Therapeutics, Inc.、Phio Pharmaceuticals Corp.较为活跃,换手率分别为1290.07%、843.09%、158.18%,振幅较大的相关个股有Theriva Biologics, Inc.、Rigel Pharmaceuticals, Inc.、杰龙,振幅分别为22.79%、15.72%、12.88%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721333894ef5173&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025050721333894ef5173&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["LENZ","BK4139","APVO","BK4007"],"gpt_icon":0},{"id":"2533592977","title":"Aptevo Therapeutics Inc.5月5日成交额为169.69万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533592977","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533592977?lang=zh_cn&edition=full","pubTime":"2025-05-06 09:16","pubTimestamp":1746494177,"startTime":"0","endTime":"0","summary":"美东时间2025年5月5日,Aptevo Therapeutics Inc.成交额为169.69万美元,成交额较昨日增加383.67%,当日成交量为378.22万股。Aptevo Therapeutics Inc.于2025年5月5日跌12.09%,报0.44美元,该股过去5个交易日跌28.1%,年初至今跌89.79%,过去60日跌89.79%。|近5个交易日成交情况||||#|日期|成交额(美元)|成交额较昨日变化|成交量(股)|#|2025-05-05|169.69万|383.67%|378.22万|#|2025-05-02|35.08万|67.43%|74.30万|#|2025-05-01|20.95万|-55.46%|41.87万|#|2025-04-30|47.05万|47.63%|93.09万|#|2025-04-29|31.87万|-16.95%|56.70万|Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506091623a47350f1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250506091623a47350f1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","LENZ","BK4007"],"gpt_icon":0},{"id":"2533612587","title":"Aptevo Therapeutics Inc.股价重挫13.63% 市值跌32.68万美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2533612587","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2533612587?lang=zh_cn&edition=full","pubTime":"2025-05-05 21:32","pubTimestamp":1746451924,"startTime":"0","endTime":"0","summary":"北京时间2025年05月05日21时32分,Aptevo Therapeutics Inc.股票出现波动,股价大幅下跌13.63%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体跌幅为0.18%。其相关个股中,Nls Pharmaceutics Ltd C/Wts 02/02/2026、Coeptis Therapeutics Holdings Inc C/Wts 28/10/2027 、Nucana Plc涨幅较大,Nucana Plc、Scisparc Ltd.、Aptevo Therapeutics Inc.较为活跃,换手率分别为683.40%、257.03%、42.97%,振幅较大的相关个股有Polyrizon Ltd.、Nucana Plc、Scisparc Ltd.,振幅分别为21.80%、21.16%、11.76%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213204a472d788&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250505213204a472d788&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4007","BK4139","LENZ","APVO"],"gpt_icon":0},{"id":"2532384063","title":"Aptevo Therapeutics Inc.盘中异动 股价大涨5.07%报0.524美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2532384063","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2532384063?lang=zh_cn&edition=full","pubTime":"2025-05-02 22:14","pubTimestamp":1746195241,"startTime":"0","endTime":"0","summary":"北京时间2025年05月02日22时14分,Aptevo Therapeutics Inc.股票出现异动,股价急速上涨5.07%。截至发稿,该股报0.524美元/股,成交量13.6579万股,换手率2.46%,振幅5.99%。Aptevo Therapeutics Inc.股票所在的生物技术行业中,整体涨幅为0.99%。Aptevo Therapeutics Inc.公司简介:Aptevo Therapeutics Inc是一家临床阶段的研究与开发生物技术公司,专注于开发用于治疗不同类型癌症的新型免疫治疗候选药物。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502221401a4700bc0&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250502221401a4700bc0&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK4139","APVO","BK4007","LENZ"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.aptevotherapeutics.com","stockEarnings":[{"period":"1week","weight":-0.0132},{"period":"1month","weight":-0.3548},{"period":"3month","weight":-0.8515},{"period":"6month","weight":-0.9687},{"period":"1year","weight":-0.9878},{"period":"ytd","weight":-0.9652}],"compareEarnings":[{"period":"1week","weight":-0.0028},{"period":"1month","weight":0.037},{"period":"3month","weight":0.168},{"period":"6month","weight":0.0743},{"period":"1year","weight":0.1207},{"period":"ytd","weight":0.0641}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Aptevo Therapeutics Inc.于2016年2月在特拉华州注册成立。该公司是一家临床阶段的研发生物技术公司,专注于开发用于治疗不同形式癌症的新型免疫疗法候选者。该公司开发了两种多功能平台技术,用于合理设计精准免疫调节药物。该公司的主要临床候选药物APVO436和ALG.APV-527以及临床前候选药物APVO603和APVO711是使用ADAPTIR模块蛋白技术平台开发的。该公司的临床前候选药物APVO442是利用ADAPTIR-FLEX模块蛋白技术平台开发的。该公司的ADAPTIR和ADAPTIR-FLEX平台旨在产生能够增强人体免疫系统对抗癌细胞的单特异性、双特异性和多特异性候选抗体。","yearOnYearQuotes":[{"month":1,"riseRate":0.222222,"avgChangeRate":-0.073504},{"month":2,"riseRate":0.222222,"avgChangeRate":-0.064327},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.20989},{"month":4,"riseRate":0.222222,"avgChangeRate":-0.15126},{"month":5,"riseRate":0.555556,"avgChangeRate":-0.026729},{"month":6,"riseRate":0.222222,"avgChangeRate":-0.08688},{"month":7,"riseRate":0.444444,"avgChangeRate":-0.033799},{"month":8,"riseRate":0.125,"avgChangeRate":-0.135772},{"month":9,"riseRate":0.111111,"avgChangeRate":-0.070045},{"month":10,"riseRate":0.222222,"avgChangeRate":-0.010761},{"month":11,"riseRate":0.555556,"avgChangeRate":0.546943},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.110269}],"exchange":"NASDAQ","name":"Aptevo Therapeutics Inc.","nameEN":"Aptevo Therapeutics"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.3","shortVersion":"4.34.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Aptevo Therapeutics Inc.,APVO,Aptevo Therapeutics Inc.股票,Aptevo Therapeutics Inc.股票老虎,Aptevo Therapeutics Inc.股票老虎国际,Aptevo Therapeutics Inc.行情,Aptevo Therapeutics Inc.股票行情,Aptevo Therapeutics Inc.股价,Aptevo Therapeutics Inc.股市,Aptevo Therapeutics Inc.股票价格,Aptevo Therapeutics Inc.股票交易,Aptevo Therapeutics Inc.股票购买,Aptevo Therapeutics Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Aptevo Therapeutics Inc.(APVO)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Aptevo Therapeutics Inc.(APVO)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}